143 related articles for article (PubMed ID: 11869319)
1. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs.
Ikeda K; Ishida K; Sato N; Koeda K; Aoki K; Kimura Y; Iwaya T; Ogasawara S; Iijima S; Nakamura R; Uesugi N; Maesawa C; Saito K
Dis Esophagus; 2001; 14(3-4):197-201. PubMed ID: 11869319
[TBL] [Abstract][Full Text] [Related]
2. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.
Hurmuzlu M; Øvrebø K; Monge OR; Smaaland R; Wentzel-Larsen T; Viste A
World J Surg Oncol; 2010 Jun; 8():46. PubMed ID: 20515502
[TBL] [Abstract][Full Text] [Related]
4. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
[TBL] [Abstract][Full Text] [Related]
5. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.
Lee JL; Park SI; Kim SB; Jung HY; Lee GH; Kim JH; Song HY; Cho KJ; Kim WK; Lee JS; Kim SH; Min YI
Ann Oncol; 2004 Jun; 15(6):947-54. PubMed ID: 15151953
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion.
de Manzoni G; Pedrazzani C; Pasini F; Bernini M; Minicozzi AM; Giacopuzzi S; Grandinetti A; Cordiano C
J Surg Oncol; 2007 Mar; 95(3):261-6. PubMed ID: 17323341
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Choong NW; Mauer AM; Haraf DC; Ferguson MK; Sandler AB; Kesler KA; Fishkin PA; Ansari RH; Wade J; Krauss SA; Sciortino DF; Posner MC; Kocherginsky M; Hoffman PC; Szeto L; Vokes EE
Med Oncol; 2011 Dec; 28 Suppl 1():S152-61. PubMed ID: 20730572
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus.
Zenda S; Kojima T; Kato K; Izumi S; Ozawa T; Kiyota N; Katada C; Tsushima T; Ito Y; Akimoto T; Hasegawa Y; Kanamaru M; Daiko H
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):976-984. PubMed ID: 27745985
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy for inoperable squamous cell carcinoma of the esophagus potentially followed by surgery.
Tsujinaka T; Shiozaki H; Kido Y; Murata A; Nishijima J; Inoue M; Iijima S; Inoue T; Mori T
J Surg Oncol; 1995 Jan; 58(1):50-6. PubMed ID: 7823574
[TBL] [Abstract][Full Text] [Related]
13. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.
Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K
Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.
Posner MC; Gooding WE; Landreneau RJ; Rosenstein MM; Clarke MR; Peterson MS; Lembersky BC
Cancer J Sci Am; 1998; 4(4):237-46. PubMed ID: 9689982
[TBL] [Abstract][Full Text] [Related]
16. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
[TBL] [Abstract][Full Text] [Related]
17. Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus.
Chan R; Morrill S; Freeman D; Colman M; Zwischenberger J
Dis Esophagus; 2001; 14(3-4):202-7. PubMed ID: 11869320
[TBL] [Abstract][Full Text] [Related]
18. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma.
Tsujinaka T; Shiozaki H; Yamamoto M; Inoue M; Yano M; Doki Y; Monden M
Am J Surg; 1999 Jun; 177(6):503-6; discussion 507. PubMed ID: 10414703
[TBL] [Abstract][Full Text] [Related]
19. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
20. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]